Get startedLog in
    Picture of Gland Pharma logo

    GLAND — Gland Pharma Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Gland Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line9,92913,34816,18610,54611,325
    Depreciation
    Non-Cash Items-624-815-1,385-1,085-1,210
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-3,241-7,472-7,996-7,288-3,593
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities7,0096,0497,9083,6409,968
    Capital Expenditures-1,947-2,288-5,221-2,231-3,983
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-5,714-12,952-4,80514,313-13,587
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-7,661-15,240-10,02612,082-17,569
    Financing Cash Flow Items-62.5-23.3-34-62.9-256
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-68.712,385349149-7,994
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-6693,230-1,73615,901-15,518